Locus of control and anti-hypertensive medication adherence in Ghana

Locus of control and anti-hypertensive medication adherence in Ghana

 

Irene Akwo Kretchy^1,2,&, Frances Thelma Owusu-Daaku¹, Samuel Danquah³

 

¹Department of Clinical and Social Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Ghana, ²Department of Pharmacy Practice and Clinical Pharmacy, University of Ghana School of Pharmacy, College of Health Sciences, Ghana, ³Department of Psychology, University of Ghana, Legon, Ghana

 

 

^&Corresponding author
Irene Akwo Kretchy, Department of Clinical and Social Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology; or Department of Pharmacy Practice and Clinical Pharmacy, University of Ghana School of Pharmacy, College of Health Sciences, Ghana

 

 

 

 

As the global disease burden shifts from communicable to non-communicable diseases, hypertension has become a key public health problem. Hypertension is the leading risk factor for cardiovascular diseases and is a major cause of death globally [1]. Hypertension affects approximately 11% - 42% of Africans [2-5]. Twagirumukiza and colleagues [3] have projected that by 2025, 125.5 million people in sub-Saharan Africa will be affected. The prevalence of hypertension in Ghana has been estimated at 25% in urban and 20% in rural populations [6].

 

Hypertension requires long term management and follow-up. Adherence to therapy is a key component of management. Both pharmacologic (medications) and non-pharmacologic (psychotherapy, lifestyle) therapies are prescribed for hypertensive patients with the expectation that patients will be adherent [7-9]. However, many patients fail to adhere to treatment recommendations resulting in less than optimal treatment [10, 11]. The WHO estimates that adherence rate to pharmacotherapy for hypertension is 50% [12]. According to Buabeng and colleagues [13], the level of non-adherence to anti-hypertensive medication in Ghana is about 93%. Medication side effects are often cited as the main barrier to adherence [10-12, 14-16].

 

Personality constructs like the locus of control (LoC) can influence health behavior and impact on illness and treatment [17]. The LoC concept stems from Rotter’s social learning theory [18] which posits that individuals can be differentiated in terms of their internal or external source of control. People with an internal LoC take responsibility and decisions without any form of influence from the external world. Studies have shown that internally-driven people are more likely to adhere to prescribed treatment regimens because they believe in their ability to influence their health [19, 20]. Conversely, individuals with external LoC assign their experiences to forces in the outer world such as chance, fate or other people. Externally-driven people are thought to be less likely to adhere to therapy because of the belief that their actions may not appreciably affect health outcomes [21, 22]. Studies have shown that internal LoC is associated with adherence to daily peak expiratory flow rate monitoring recommended for asthma management [19, 21], maintaining a gluten-free diet in the control of celiac disease [23], diabetic management [24], and use of antipsychotic medications in the management of schizophrenia [22].

 

Some studies have demonstrated that individuals are not entirely internal or external in their LoC; rather they consider different sources of control [18]. This leads to an exhibition of a mixed LoC also referred to as “bilocal” LoC [3] or “responsible internal” [25]. In addition, although LoC is often thought to be stable particularly in adulthood [26, 27], there is evidence suggesting that LoC may change over time [28]. Internal health LoC is associated with knowledge and attitude, psychological state, health behaviour, and better health conditions. External health LoC, on the other hand, is linked with negative health behaviours and weak psychological state [29]. High internal LoC has been found to be beneficial when barriers to medication adherence (e.g., side-effects, forgetting to take medication, and keeping track of pills) are low.

 

Although differences in locus orientation have been shown to be associated with health behaviour, differences in adherence behaviour in relation to LoC may be due to differences in the cultures of particular groups of people. Culture often drives societal values and distinguishes different groups of people [30]. Contrary to many studies conducted in the West that have found an association between a high internal LoC and positive health behaviours, studies conducted in other parts of the world have found different associations. Azlin and colleagues [31] observed, for example, that Malaysians with high internal LoC reported poor adherence to medications. This observation underscores cultural variability in locus orientation. Unlike western cultures which are more individualistic encouraging internal LoC, Eastern cultures tend to value collectivism, thus promoting external LoC [32, 33]. In individualistic cultures, individuals have greater personal autonomy and value the pursuance of individual goals of health and well-being to a large extent. In collectivist cultures however, individuals may not feel personally responsible for their health seeking behaviours due to greater social influence from the external world. Thus, an individual with an internal LoC in an individualistic culture may take great responsibility for his or her successes and failures about health whereas an individual with an internal LoC in a collectivist culture may take responsibility for successes and failures while placing emphasis on external factors. Although in South Africa one study showed a preponderance of bi-local expectancies [34], information regarding having this mixed Loc in view of the African cultural belief and medication adherence is inadequate. Additionally, cultural orientations may affect the responses of hypertensive patients towards their experiences with side effects. In general, however, there is a paucity of information regarding LoC, side effects and hypertensive medication adherence among Africans [20].

 

This study sought to examine the association between LoC and adherence to medications among hypertensive patients in Ghana. In addition, we assessed the possible influence of LoC on the association between medication side effects and adherence behaviour. We postulated that hypertensive patients with high internal LoC would be more adherent than those with external LoC. We also hypothesized that medication side effects would be associated with non-adherence, but that the association will be moderated by LoC.

 

 

Study setting

 

This cross-sectional study was conducted in two tertiary hospitals in southern and northern Ghana between May and July 2012. Korle-Bu Teaching Hospital (KBTH) is the premier and largest teaching hospital. KBTH serves the Greater Accra Region and surrounding areas. Komfo Anokye Teaching Hospital (KATH) is located in Kumasi, the Regional Capital of Ashanti Region. KATH is the second-largest hospital in the country. The hospital serves as the main referral facility for the Ashanti, Brong Ahafo, Northern, Upper East and Upper West Regions. Ashanti and Greater Accra are predominantly urban and are estimated to be home to over one-third of Ghanaians [35]. Both hospitals serve patients from diverse socio-cultural backgrounds.

 

Study population

 

Study participants consisted of 400 hypertensive patients attending KBTH (n=200) and KATH (n=200). The minimum total sample size was determined using the statistical formula below where N is the required sample size, Z is the critical value corresponding to a 95% confidence interval (1.96), P is the estimated prevalence of hypertension (28.7%), and d is the desired level of precision taken here as 0.05 [36]:

 

 

Par¬ticipants were selected through a simple random process using a random number table [37]. Participants were adult male and female patients (above 18 years), diagnosed with hypertension or who were co-morbid with other health conditions and reported having a prescription for at least one anti-hypertensive medication. Newly diagnosed, or patients who were not on any form of prescribed anti-hypertensive medications as well as in-patients, pregnant women and the incapacitated were excluded from this study.

 

Study instrument

 

Data were collected using a researcher-administered semi-structured interview. Each interview lasted about 30 minutes. Measures included socio-demographic characteristics, health locus of control, adherence to medication, and side effects experienced. Health locus of control was assessed using the Multidimensional Health Locus of Control (MHLC) form C [38]. The MHLC scale measures variations in LoC beliefs in relation to health conditions [39] and assesses the extent to which a person believes that health status is influenced by one’s actions, ‘chance’ and ‘powerful others’ (specifically ‘doctors’ and ‘others’) [40]. The MHLC Form C included 18 items assessing whether the respondents agreed or disagreed with belief statements about hypertension (Cronbach’s alpha= 0.90).

 

Medication adherence was measuring using the Morisky Medication Adherence Scale (MMAS) [41] which comprises 8 items (Cronbach’s alpha = 0.79). MMAS scores can range from zero to eight with higher scores reflecting higher adherence. Participants were categorized as having low adherence, medium adherence and high adherence based on the number of positive responses obtained. Patients who scored low and moderate were eventually grouped in one category for analysis purposes [42].

 

The frequency at which patients experience various side effects associated with different anti-hypertensive medications was assessed with the 18-item Hypertensive Medication Side Effect Experience Scale (HMSEES) (Cronbach’s alpha = 0.80). Responses were scored on a 5-point frequency response scale that ranged from never (0), rarely (1), sometimes (2), very often (3), and always (4). Item scores were added and responses categorized as low (score of 0-24), moderate (25-48) and high (49-72) experience of side effects.

 

Data analysis

 

Data were analyzed using the Statistical Package for Social Sciences (SPSS) version 20 and R version 2.15.2. Descriptive statistics were computed to summarize the characteristics of study participants. The chi-square test was used to assess the bivariate association between health LoC and socio-demographic characteristics. Logistic regression analysis was used to assess the association between health LoC, side effects and medication adherence while adjusting for socio-demographic characteristics.

 

Ethical issues

 

The Institutional Review Boards at the Noguchi Memorial Institute for Medical Research, Accra, and Committee of Human Research, Publications and Ethics, Kumasi approved all procedures used in this study. All participants provided informed consent from prior to data collection.

 

 

Four hundred hypertensive patients participated in the study (Table 1). The majority of study participants were 50- 59 years old, female (62.7%), and married (63.5%). Fifty-four percent had attained a minimum of secondary school education and 89.5% were Christians. Eighty-three percent of participants resided in urban communities. Eighty percent had been diagnosed with hypertension for 10 years or less.

 

Variations in internal and external LoC were minimal indicating a mixed LoC (Table 1). Though patients demonstrated a mixed internal and external LoC orientation, responses were skewed towards externality. Chi square test results are shown in Table 2. Sex was significantly associated with internal LoC (X²= 12.9574, p = 0.0003) and external LoC (X²= 8.9369, p = 0.0028). Education was significantly associated with external LoC (X²= 4.5526, p = 0.0329) but not internal LoC (X²= 0.0273, p = 0.8687). The MMAS scores showed that majority (93.3%) of hypertensive patients poorly adhered to their medications (Table 1). Participants cut back or stopped taking their medication without telling the doctor because they felt worse when they took it, or stopped taking the medicine when they felt their blood pressure was under control. About 60% of patients experienced moderate to severe side effects associated with anti-hypertensive medications (Table 1). These side effects included difficulty sleeping, erectile dysfunction, reduced sexual drive, constipation, chest pain, depressed mood, headaches, cough, fatigue, and dizziness.

 

The logistic regression model results are presented in Table 3. Participants with high internal LoC had 68% lower odds of non-adherence than those with low internal LoC (OR = 0.32 (95% CI 0.11 – 0.95), p = 0.039). Likewise, participants exhibiting low internal LoC had 5.64 times greater odds of being non-adherent than participants with low external LoC (OR = 5.64 (1.14 – 27.87), p = 0.034). Participants scoring low on the “others” subscale of external LoC, had 81% lower odds of non-adherence than their counterparts with high “others” (OR = 0.19 (0.06 – 0.57), p = 0.003) Additionally, participants who experienced moderate to high side effects were more likely to be non-adherent than those who had low experiences of side effects (OR = 4.84 (1.07 – 21.85), p = 0.04). Participants reporting both medication side effects and external LoC had 2.4 times greater odds of non-adherence than participants with side effects and internal LoC (OR = 2.4 (0.35 – 16.31), p <0.001).

 

 

This study examined the association between personality characteristics (LoC) and medication adherence behaviour while taking into account medication side effects. We found that a very high proportion of patients (93%) did not adhere to their medications. The low level of adherence is similar to that reported by Buabeng and colleagues among hypertensive patients in Ghana [13]. These results underscore the need for interventions to improve adherence levels..

 

The health LoC construct has been one of the most widely considered predictors of health-related behaviour of patients. Previous research on medication adherence provides evidence linking internal LoC with adherence [20] and non-adherence [31]. The HLoC results from this study showed that hypertensive patients exhibited a blend of LoC. However, it is worth noting that though patients responded highly for both internal and external orientations, the pattern was skewed towards externality particularly, “doctors”. It is possible that although patients feel that they are responsible for their health they also attribute health-related outcomes to doctors. This leads to the belief that the health of hypertensive patients is controllable, either by themselves or doctors, and is not as a result of chance, fate or luck [25]. Patients who are internally-driven have a sense of self-responsibility in following recommendations made by health professionals. According to Wallston and Wallston [25], mixed LoC could be a helpful coping mechanism for patients with chronic conditions and successful management of hypertension may mean patients encouraging themselves to adhere to their doctors’ recommended regimen. In general, there is a paucity of information on the relationship between bilocal LoC and medication adherence behaviour although the general evidence from other studies predominantly associate bilocal LoC with positive attributes and behaviours [43, 44].

 

The presence of characteristics associated with low internal LoC and high external “others’ accounted for the non-adherence observed. That is, patients with low internal LoC are less likely to take full responsibility for their illness and health behaviours. Additionally, having a high external LoC makes patients more likely to attribute their health actions to external forces instead of taking personal responsibility. Therefore observing a significant relationship between the variables and non-adherence confirmed that patients had a reduced tendency to adhere to prescribed treatment regimen, because they believe they cannot affect their own health behaviours. These findings are similar to studies by Omeje and Nebo (2011) [20] and Combes and Feral (2011) [22].

 

Though only marginally significant, results showed that women were more inclined towards internal LoC than males. This result contradicts the belief that females are less likely to possess internal LoC than males [45,46] while corroborating findings by Hamedoglu et al, 2012 [47] as well as Sariçam et al [48]. Internality was also associated with higher education.

 

Medication side effects were observed to be a potential factor that could repress adherence. The majority of hypertensive patients pointed out that they experienced moderate to high side effects which included difficulty sleeping, erectile dysfunction, reduced sexual drive, constipation, chest pain, depressed mood, headaches, cough, fatigue and dizziness. This corroborates well-documented evidence on medication side effects being a major cause of non-adherence to therapy [12,14]. External LoC did not considerably influence medication adherence yet when employed, external LoC significantly moderated the relationship between side effects and adherence. The study shows that, external LoC on its own may not be a true predictor of adherence behaviour, but, in the presence of barriers to medication intake such as side effects, the role of external LoC is highly important, contrary to what has been reported in a prior study [49]. However, the possibility of patients managing high external LoC and employing an enhanced internality as an underlining preserve in managing experiences of side effects associated with medications can still be suggested. With the existence of barriers to medication intake, intervention programmes for non-adherence can be directed towards a greater involvement of personality characteristics such as LoC.

 

Some limitations must be acknowledged. First, although we selected participants from tertiary institutions that serve a diverse population, results may not be widely generalizeable. Second, we included patients with co-morbid health conditions, which might have affected the outcomes we observed.

 

 

Medication non-adherence dominates as a major health problem. The results of this study bring to bear a persistent problem of non-adherence to anti-hypertensive medication among the Ghanaian population, hence, highlighting the need for intervention programmes to enhance adherence to pharmacotherapy. The LoC construct has been one of the most widely considered predictors of health-related behaviour among patients. This study showed that hypertensive patients exhibited a mixed LoC referred to as “bilocal” LoC. Yet this mixed orientation was skewed towards externality. Experiences of medication side effects and medication non-adherence behaviour appear to be linked. Multifaceted intervention programmes that take into account factors like LoC may improve anti-hypertensive medication adherence.

 

 

The authors declare that they have no competing interests.

 

 

Irene Kretchy: Data collection, analysis and interpretation of results, writing of manuscript; Frances Owusu-Daaku: contributed to development of concept, study design and review of manuscript; Samuel Danquah: contributed to development of concept, study design and review of manuscript.

 

 

We express our profound appreciation to the study participants and field assistants who helped in making this research a success. This research was funded by an African Doctoral Dissertation Research Fellowship award offered by the African Population and Health Research Center (APHRC) in partnership with the International Development Research Centre (IDRC) and a University of Ghana Faculty Development Grant offered by the Office of Research, Innovation and Development (ORID). We thank Prof. Kenneth Wallston and Dr. Donald Morisky for the study tools as well as Dr. Kwadwo Asamoah Kusi.

 

 

Table 1: Descriptive characteristics of participants (N=400)

Table 2: Comparing LoC with sex and educational level

Table 3: Logistic regression model for LoC and side effects in relation to medication non-adherence behaviour

 

 

1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2012; 380 (9859), 2224-2260. PubMed | Google Scholar


2. Adedoyin RA, Mbada CE, Balogun MO et al. Prevalence and pattern of hypertension in a semiurban community in Nigeria. Eur J Cardiovasc Prev Rehab. 2008; 15:683-687. PubMed | Google Scholar


3. Twagirumukiza M, De Bacquer D, Kips JG, de Backer G, Stichele RV & Van Bortel LM. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. J Hypertens. 2011; 29(7): 1243-1252. PubMed | Google Scholar


4. Tesfaye F, Byass P, Wall S. Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic. BMC Cardiovasc Disord. 2009; 9:39. PubMed | Google Scholar


5. World Health Organization. STEPS Fact Sheet. Brazzaville: WHO AFRO. 2008. Google Scholar


6. Bosu WK. Epidemic of hypertension in Ghana: a systematic review. BMC Public Health. 2010; 10:418. PubMed | Google Scholar


7. Brown MT, Bussell JK. Medication adherence: WHO cares?. Mayo Clin Proc. 2011; 86 (4):304–314. PubMed | Google Scholar


8. Nakao M, Yano E, Nomura S, Kuboki T. Blood Pressure-lowering effects of biofeedback treatment in hypertension: a meta-analysis of randomized controlled trials. Hypertens Res. 2003; 26(1):37-46. PubMed | Google Scholar


9. Willency H. Management of hypertension. Patientplus. 2010; 23. Google Scholar


10. Kabir M, Iliyasu Z, Abubakara IS, Jibrilb M. Compliance to medication among hypertensive patients in Murtala Mohammed Specialist Hospital, Kano, Nigeria. J of CM & Primary Health Care. 2004;16 (1): 16-20. PubMed | Google Scholar


11. Agyemang C, Bruijnzeels MA, Owusu-Dabo E. Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa. J Hum Hypertens. 2006; 20: 67–71. PubMed | Google Scholar


12. De Geest S, Sabate E. Adherence to long-term therapies: evidence for action. European J Cardiovasc Nurs. 2003; 2: 323. PubMed | Google Scholar


13. Buabeng KO, Matowe L, Plange-Rhule J. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharmaceut Sci. 2004; 7 (3) :350-352. PubMed | Google Scholar


14. Okoro RN, Ngong, CK. Assessment of patient’s antihypertensive medication adherence level in non-comorbid hypertension in a tertiary hospital in Nigeria. Int J Pharm Biomed Sci. 2012; 3(2): 47-54. PubMed | Google Scholar


15. Ho MP, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009; 119: 3028-3035. PubMed | Google Scholar


16. Osterberg L, Blaschke T. Adherence to medication. New Engl J Med. 2005; 353:487–497. PubMed | Google Scholar


17. Singh A. Personality characteristics, locus of control and hostility among alcoholics and non-alcoholics. IJPS. 2011; 3(1): 99 – 105. PubMed | Google Scholar


18. Lynam I, Catley D, Goggin K, Rabinowitz JL, et al. Autonomous regulation and locus of control as predictors of antiretroviral medication adherence. J Health Psychol. 2009; 14: 578. PubMed | Google Scholar


19. Burkhart PV, Rayens MK. Self-concept and health locus of control: factors related to children's adherence to recommended asthma regimen. Pediatr Nurs. 2005; 31(5):404-9. PubMed | Google Scholar


20. Omeje O, Nebo C. The Influence of locus of control on adherence to treatment regimen among hypertensive patients. Patient Prefer Adherence. 2011; 5:141–148. PubMed | Google Scholar


21. Halimi L, Pry R, Pithon G, Godard P, Varrin M, Chanez P. Severe asthma and adherence to peak flow monitoring: longitudinal assessment of psychological aspects. J Psychosom Res. 2010; 69(4):331-40. PubMed | Google Scholar


22. Combes C & Feral F. Drug compliance and health locus of control in schizophrenia. Encephale. 2011; 37(1): S11-18. PubMed | Google Scholar


23. Bellini A, Zanchi C, Martelossi S, Di Leo G, Not T, Ventura A. Compliance with the gluten-free diet: the role of locus of control in celiac disease. J Pediatr. 2011; 158(3):463-466. PubMed | Google Scholar


24. Morowatisharifabad MA, Mahmoodabad SS, Baghianimoghadam MH, Tonekaboni NR. Relationships between locus of control and adherence to diabetes regimen in a sample of Iranians. Int J Diabetes Dev Ctries. 2010; 30(1):27-32. PubMed | Google Scholar


25. Wallston KA, Wallston BS. Who is responsible for your health: the construct of health locus of control. In Sanders G & Suls J(Eds.) Social Psychology of Health and Illness. Hillsdale, N.J.: Lawrence Erlbaum & Associates. 1982; 65-95. PubMed | Google Scholar


26. Cebi M. Locus of control and human capital investment revisited. J Hum Resour. 2007; 17: 919-932. PubMed | Google Scholar


27. Schurer S. Discrete heterogeneity in the effects of health shocks on labour market outcomes. Melbourne Institute Working Paper. 2008; 19/08. PubMed | Google Scholar


28. Heineck G, Anger S. The returns to cognitive abilities and personality traits in Germany. Labour Economics. 2010; 17: 535-546. PubMed | Google Scholar


29. Malcarne VL, Drahota A, Hamilton NA. Children's health- related locus of control beliefs: ethnicity, gender, and family income. Child Health Care. 2005; 34:47–59. PubMed | Google Scholar


30. Theimann NM, April K, Blass E. Context tension: Cultural influences on leadership and management practice. SoL Reflections. 2006; 7: 38-51. PubMed | Google Scholar


31. Azlin B, Hatta S, Norzila Z, Sharifa Ezat WP. Health locus of control among non-compliance hypertensive patients undergoing pharmacotherapy. MJP. 2007; 16 (1): 20 - 39. PubMed | Google Scholar


32. Spector PE, Cooper CL, Sanchez JI, et al. Locus of control and well-being at work: How generalizable are Western findings?. Acad Manage J. 2002; 45: 453-466. PubMed | Google Scholar


33. Stocks A, April KA, Lynton N. Locus of control and subjective well-being – a cross-cultural study. Probl Perspect Manag. 2012; 10 (1) :17. PubMed | Google Scholar


34. Jackson T. International HRM: A cross-cultural approach. 2002; London: Sage. Google Scholar


35. Gyapong J, Garshong B, Akazili J, Aikins M, et al. Critical analysis of Ghana’s health system with a focus on equity challenges and the national health insurance. SHIELD Workpackage 1 Report. 2007. PubMed | Google Scholar


36. Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. AOS. 2006; 1: 9-14. PubMed | Google Scholar


37. Gravetter FJ, Forzano LB. Research Methods for Behavioural Sciences. 4th Ed. Australia: Thomson Wadsworth. 2009; 519-521. PubMed | Google Scholar


38. Krousel-Wood MA, Islam T, Webber LS, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag C. 2009; 15 (1): 59-66. PubMed | Google Scholar


39. Wallston KA, Wallston BS, DeVellis R. Development of the multidimensional health locus of control (MHLC) scales. Health Educ Monogr. 1978; 6(2): 160–170. PubMed | Google Scholar


40. Wallston KA, Stein MJ, Smith CA. Form C of the MHLC Scales: A Condition-specific measure of locus of control. J Pers Assess. 1994; 63: 534–553. PubMed | Google Scholar


41. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008; 10 (5):348-54. PubMed | Google Scholar


42. Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens. 2004; 18: 607–613. PubMed | Google Scholar


43. April K, Dharani B, Peters BKG. Impact of locus of control expectancy on level of well-being. RES. 2012; 4 (2): 124 – 137. PubMed | Google Scholar


44. Masthoff J. Design and evaluation of a navigation agent with a mixed locus of control. Cerri SA, Gouarderes G, Paraguacu F (eds), in: Intelligent Tutoring Systems: Proceedings ITS 2002: 6th International Conference, ITS 2002, Biarritz, France, June 2-7, 2002. Google Scholar


45. Holland C, Geraghty J, Shah K. Differential moderating effect of locus of control on effect of driving experience in young male and female drivers. Pers Indiv Differ. 2010; 48: 821-826. PubMed | Google Scholar


46. Jain S, Singh AP. Locus of control in relation to cognitive complexity. IAAP. 2008; 34(1): 107-113. PubMed | Google Scholar


47. Hamedoglu MA, Kantor J and Gülay E. The effect of locus of control and culture on leader preferences. IOJES. 2012; 4(2): 319-324. PubMed | Google Scholar


48. Sariçam H, Duran A, Çardak M, Halmatov M. The examination of pre-school teacher candidates’ academic locus of control levels according to gender and grade. MIJE. 2012; 2(2): 67-74. PubMed | Google Scholar


49. Hong, TB, Oddone EZ, Dudley TK, Bosworth HB. Medication barriers and anti-hypertensive medication adherence: the moderating role of locus of control. Psychol Health Med. 2006; 11 (1): 20-8. PubMed | Google Scholar